Bradford T. Whitmore - Feb 7, 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
10%+ Owner
Signature
Bradford T. Whitmore
Stock symbol
CLSD
Transactions as of
Feb 7, 2024
Transactions value $
$599,999
Form type
4
Date filed
2/9/2024, 01:00 PM
Previous filing
Dec 8, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $600K +444K +10.97% $1.35 4.5M Feb 7, 2024 Direct
holding CLSD Common Stock 2.35M Feb 7, 2024 by Grace Brothers, LP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Warrant Purchase $0 +444K $0.00 444K Feb 7, 2024 Common Stock 444K $1.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Bradford T. Whitmore is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,350,152 shares of Common Stock.